ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Gene Expression"

  • Abstract Number: 137 • 2017 Pediatric Rheumatology Symposium

    Chromatin Landscapes and Genetic Risk For Juvenile Idiopathic Arthritis

    James Jarvis1, Lisha Zhu2, Lai Ping Wong3, Tao Liu4, Kaiyu Jiang3 and Yanmin Chen3, 1Pediatrics, SUNY Buffalo School of Medicine, Buffalo, NY, 2Biochemistry, University at Buffalo, Buffalo, NY, 3Pediatrics, University at Buffalo, Buffalo, NY, 4Department of Biochemistry, University at Buffalo, Buffalo, NY

    Background/Purpose: The transcriptomes of peripheral blood cells in children with juvenile idiopathic arthritis (JIA) show distinct transcriptional aberrations that suggest impairment of transcriptional regulation. To…
  • Abstract Number: 8 • 2017 Pediatric Rheumatology Symposium

    Examination of Reported Risk Loci from Candidate Gene Studies of Systemic Juvenile Idiopathic Arthritis Identifies Link between IL1RN Variation and both Disease Susceptibility and Response to Interleukin-1 Directed Therapy

    Victoria Arthur1, Emily Shuldiner1, Anne Hinks2, The International Childhood Arthritis Genetics (INCHARGE) Consortium3, Patricia Woo4, Wendy Thomson2, Elaine F. Remmers5 and Michael J. Ombrello1, 1Translational Genetics and Genomics Unit, NIAMS, NIH, Bethesda, MD, 2Arthritis Research UK Centre for Genetics and Genomics,The University of Manchester, Manchester, United Kingdom, 3INCHARGE Consortium, Bethesda, MD, 4Paediatric Rheumatology Unit, University College London, London, United Kingdom, 5Inflammatory Disease Section, NHGRI, NIH, Bethesda, MD

    Background/Purpose: Systemic JIA (sJIA) is a childhood inflammatory disease whose pathophysiology is poorly understood. sJIA is phenotypically heterogeneous with variable manifestations and responses to treatment.…
  • Abstract Number: 68 • 2016 ACR/ARHP Annual Meeting

    Epigenetic and Expression Analysis of Ankylosing Spondylitis Association Loci Point to Key Cell Types Driving Disease

    Zhixiu Li1, Katelin Haynes2, Gethin P. Thomas3, Tony J. Kenna1, Paul Leo1 and Matthew A. Brown1, 1Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, Australia, Brisbane, Australia, 2University of Queensland Diamantina Institute, Brisbane, Australia, Brisbane, Australia, 3Research Office, Charles Sturt University, Wagga, Australia, Wagga, Australia

    Background/Purpose: Susceptibility to ankylosing spondylitis (AS) is primarily genetic; thus far 113 susceptibility variants for AS have been identified. However, most of the AS associated…
  • Abstract Number: 1217 • 2016 ACR/ARHP Annual Meeting

    Identification of Sjogren’s Syndrome-Associated Long Non-Coding RNAs That Are Co-Expressed with Key Protein-Coding Transcripts Involved in Dysregulated Interferon Responses

    John A. Ice1, Indra Adrianto1, Michelle L. Joachims2, Jennifer A. Kelly2, Graham B. Wiley1, Astrid Rasmussen1, Kiely Grundahl3, Glen D. Houston4, David M. Lewis4, Lida Radfar5, Donald U. Stone6,7, Joel M. Guthridge2, Barbara M. Segal8, Nelson L. Rhodus9, James Chodosh10,11, Raj Gopalakrishnan12, Andrew J.W. Huang13, Pamela J Hughes14, Michael D. Rohrer15, Judith A. James16,17,18, Courtney G. Montgomery1, R. Hal Scofield1,18,19, Patrick Gaffney1, Kathy L. Sivils2,16 and Christopher J. Lessard1,16, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 5Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 7Department of Ophthalmology, Johns Hopkins University, Baltimore, MD, 8Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 9Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 10Harvard Medical School, Boston, MA, 11Massachusetts Eye and Ear Infirmary, Boston, MA, 12Diagnostic and Biological Sciences, Division of Oral Pathology, University of Minnesota School of Dentistry, Minneapolis, MN, 13Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, MO, 14Department of Oral and Maxillofacial Surgery, Oregon Health & Science University School of Dentistry, Portland, OR, 15Hard Tissue Research Laboratory, University of Minnesota School of Dentistry, Minneapolis, MN, 16Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 17Clinical Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 18Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 19US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: The “interferon signature”, marked by transcriptional upregulation of interferon (IFN)-inducible (IFI) genes, is a common finding in Sjögren’s syndrome (SS) that is associated with…
  • Abstract Number: 2426 • 2016 ACR/ARHP Annual Meeting

    Transcriptomic Analysis of Immune Subsets in Juvenile Dermatomyositis before and after Treatment Identifies Novel Pathways Involved in Pathogenesis

    Claire Deakin1, Georg Otto2,3, Meredyth Wilkinson4, Stefanie Dowle2,3, Stefania Simou5, Lucy Marshall6, Elizabeth Rosser6, Daniel Kelberman2,3, Lucy R Wedderburn6,7,8 and Juvenile Dermatomyositis Research Group (JDRG), 1Infection, Inflammation and Rheumatology Section,, UCL Institute of Child Health, London, United Kingdom, 2Genetics & Genomic Medicine Programme, UCL Institute of Child Health, London, United Kingdom, 3National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom, 4Division of Medicine, University College London, London, United Kingdom, 5Infection, Inflammation and Rheumatology, UCL Institute of Child Health, London, United Kingdom, 6Infection, Inflammation and Rheumatology Section, UCL Institute of Child Health, London, United Kingdom, 7Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, United Kingdom, 8Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

    Background/Purpose:  Although proximal muscle weakness and skin rash are the typical features of juvenile dermatomyositis (JDM), little is known about disease pathogenesis, why other features…
  • Abstract Number: 77 • 2016 ACR/ARHP Annual Meeting

    Integrated Analysis of Microrna and mRNA Expression Profiles Related to Cardiovascular Disease in Monocytes from Systemic Lupus Erythematosus and Primary Antiphospholipid Syndrome Patients

    Carlos Perez-Sanchez1, Maria Ángeles Aguirre Zamorano1, Patricia Ruiz-Limon2, Nuria Barbarroja1, Yolanda Jiménez-Gómez1, Maria Carmen Abalos-Aguilera2, Ivan Arias de la Rosa2, María Galindo3, Eduardo Collantes-Estévez1, Maria Jose Cuadrado4 and Chary Lopez-Pedrera1, 1Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 2Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 3Servicio de Reumatología, Hospital 12 de Octubre, Madrid, Spain, 4St Thomas Hospital, Lupus Research Unit, London, United Kingdom

    Background/Purpose: The interplay between miRNAs and their mRNA targets might constitute an important mechanism in the regulation of the proatherothrombotic status of SLE and APS…
  • Abstract Number: 1473 • 2016 ACR/ARHP Annual Meeting

    Expression of Vitamin D Receptor Associated Genes in the Aorta of Coronary Artery Disease Patients with and without Rheumatoid Arthritis

    Ingvild Oma1, Sverre Holm2,3, Jacqueline Kirsti Andersen4, Ole K. Olstad5, Ida G. Fostad6, Torstein Lyberg5, Sven Martin Almdahl7, Øyvind Molberg8 and Ivana Hollan9,10,11, 1Innlandet Hospital Trust, Lillehammer, Norway, 2Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway, 3Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway, 4Norwegian University of Science and Technology, Gjøvik, Norway, 5Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway, 6Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway, 7Department of Cardiothoracic Surgery, University Hospital of North Norway, Tromsø, Norway, 8Oslo University Hospital, Oslo, Norway, 9Brigham and Women’s Hospital, Boston, MA, 10Harvard Medical School, Boston, MA, 11Lillehammer Hospital for Rheumatic Diseases, Lillahammer, Norway

    Background/Purpose: Vitamin D has an important role in the immune system, and has been linked to inflammation, rheumatoid arthritis (RA) and coronary artery disease (CAD)[1,…
  • Abstract Number: 2429 • 2016 ACR/ARHP Annual Meeting

    Mechanisms for the Development of Lung Fibrosis in Sting-Associated Vasculopathy with Onset in Infancy (SAVI)

    Adriana Almeida de Jesus1, Louise Malle1, Dan Yang2, Bernadette Marrero1, Yin Liu3, Gina A. Montealegre Sanchez1, Dawn C. Chapelle4, Hanna Kim4, Michelle O'Brien4, Gregor Dueckers5, Suzanne Ramsey6, Joseph R. Fontana7, Steven M. Holland8, Yan Huang1, Suvimol Hill9, Laisa Santiago10, Benito Gonzalez11, Paul Brogan12, Juergen Brunner13, Ebun Omoyinmi14, Athimalaipet V Ramanan15, Amy Paller16, Olcay Y. Jones17, Seza Ozen18, Stephen Brooks4, Zuoming Deng4, Manfred Boehm19, Raphaela Goldbach-Mansky20 and Helmut Wittkowski21, 1National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, 2National Heart, Lung, and Blood Institute (NHLBI), NIH, Bethesda, MD, 3Scientific Review Branch, NIAMS, NIH, Bethesda, MD, 4NIAMS/NIH, Bethesda, MD, 5Helios Kliniken - Kinderklinik, HELIOS Klinikum Krefeld, Krefeld, Germany, 6Pediatric Rheumatology, IWK Health Centre, Halifax, NS, Canada, 7Cardiovascular and Pulmonary Branch, NHLBI, NIH, Bethesda, MD, 8Laboratory of Clinical Infectious Disease, NIAID, NIH, Bethesda, MD, 9Radiology Department, Clinical Center, NIH, Bethesda, MD, 10Johns Hopkins All Children's Hospital Rheumatology, Saint Petersburg, FL, 11Luis Calvo Mackenna Hospital, Santiago, Chile, 12UCL Institute of Child Health and Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom, 13Department of Pediatrics, Medical University Innsbruck, Innsbruck, Austria, 14University College London Institute of Child Health, London, United Kingdom, 15University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom, 16Departments of Dermatology and Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA;, Chicago, IL, 17Pediatrics, Walter Reed National Military Medical Center, Bethesda, MD, 18Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, ANKARA, Turkey, 19Laboratory of Cardiovascular Regenerative Medicine, National Heart, Lung, and Blood Institute (NHLBI), NIH, Bethesda, MD, 20Translational Autoinflammatory Disease Studies, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, 21Department of Pediatric Rheumatology and Immunology, University Hospital of Muenster, Münster, Germany

    Background/Purpose:  STING-Associated Vasculopathy with Onset in Infancy (SAVI) is a monogenic autoinflammatory interferonopathy caused by gain-of-function mutations in TMEM173/STING, a nucleic acid sensor adaptor linked…
  • Abstract Number: 78 • 2016 ACR/ARHP Annual Meeting

    Whole Blood Gene Modules Show Differences Between Active Lupus Nephritis and Quiescent Disease As Well As Absence of Plasmablast Signature in This Adult Population

    Eric Zollars1, Gerard Hardiman2, Bethany Wolf3, Sean Courtney4, Norm Allaire5, Ann Ranger6 and Michelle Petri7, 1Rheumatology, Medical University of South Carolina, Charleston, SC, 2Medicine, Medical University of South Carolina, Charleston, SC, 3Public Health Sciences, Medical University of South Carolina, Charleston, SC, 4Medical University of South Carolina, Charleston, SC, 5BiogenIdec, Cambridge, MA, 6Unum RX, Cambridge, MA, 7Rheumatology Division, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose:   SLE is a complex disease with heterogeneous manifestations.  It seems unlikely that all patients labeled as SLE have homogenous molecular pathology.  An approach…
  • Abstract Number: 1478 • 2016 ACR/ARHP Annual Meeting

    Coronary Artery Calcification in Rheumatoid Arthritis Patients Is Not Characterized By an Increase in Genes Associated with Coronary Artery Disease in the General Population

    Ivan Ferraz-Amaro1, Robert Winchester2, Peter K. Gregersen3, Richard J. Reynolds4, Annette M. Oeser5, Cecilia P. Chung6, C. Michael Stein6, Mary Chester M. Wasko7, Jon T. Giles8 and Joan Bathon2, 1Rheumatology Division, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 2Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 3Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Med Res, Manhasset, NY, 4Medicine, University of Alabama at Birmingham, Birmingham, AL, 5Vanderbilt University Medical Center, Nashville, TN, 6Medicine, Vanderbilt University Medical Center, Nashville, TN, 7Lupus Center, Pittsburgh, PA, 8Rheumatology, Columbia University Medical Center, NY, NY

    Background/Purpose: In the general population individuals with coronary artery disease (CAD) have a significantly increased frequency of particular susceptibility single nucleotide polymorphisms (SNPs). Since CAD…
  • Abstract Number: 2561 • 2016 ACR/ARHP Annual Meeting

    A Novel Pharmacological Action of MTX on RA Fibroblast-like Synoviocytes Via Circadian Clock Genes

    Kohjin Suzuki1, Kohsuke Yoshida1, Teppei Hashimoto2, Kenta Kaneshiro1, Ayako Nakai1, Naonori Hashimoto1, Yoshiko Kawasaki2, Nao Shibanuma3, Natsuko Nakagawa4, Yoshitada Sakai5 and Akira Hashiramoto6, 1Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Department of Rheumatology, Kobe Kaisei Hospital, Kobe, Japan, 3Departmant of Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, Japan, 4Department of Orthopaedic Surgery, Konan-Kakogawa Hospital, Kakogawa, Japan, 5Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 6Department of Biophysics, Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan

    Background/Purpose: The circadian rhythm is disrupted in patients with rheumatoid arthritis (RA), and we have shown that tumor necrosis factor(TNF)-ƒ¿ inhibits the expression of circadian…
  • Abstract Number: 380 • 2016 ACR/ARHP Annual Meeting

    Linear Discriminant Analysis of Cultured Fibroblast-like Synoviocytes Identifies 6 Candidate Genes Which Predict Extended Course in Juvenile Idiopathic Arthritis

    AnneMarie Brescia1, Megan Simonds2, Suzanne McCahan3, Tim Bunnell3, Kathleen E. Sullivan4 and Carlos D. Rosé1, 1Pediatric Rheumatology, Thomas Jefferson University/ AI duPont Hospital for Children, Wilmington, DE, 2Nemours, Nemours Biomedical Research, Wilmington, DE, 3Nemours Biomedical Research, Wilmington, DE, 4Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: The goal of this project is the identification of informative synovial biomarkers to predict which children with oligoarticular juvenile idiopathic arthritis (JIA) will have…
  • Abstract Number: 1563 • 2016 ACR/ARHP Annual Meeting

    Enhanced Expression of mRNA for Response Gene to Complement 32 in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis

    Yu Matsueda1, Tatsuo Nagai2, Tetsuya Tomita3, Hideki Yoshikawa3, Sumiaki Tanaka1 and Shunsei Hirohata1, 1Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Kanagawa, Japan, 2Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan, 3Department of Orthopedics, Osaka University Graduate School of Medicine, Suita Osaka, Japan

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by hyperplasia of synovial lining cells, consisting of macrophage-like type A synoviocytes and fibroblast-like type…
  • Abstract Number: 2869 • 2016 ACR/ARHP Annual Meeting

    Critical Roles of IRAK4 Kinase Activity in Inflammation but Not B Cell Response in SLE  

    Chia Chi Sun1, Gang Chen2, Nuruddeen Lewis1, Andrew T Bender1, Changling Sia3, Ling Zhang2, Catherine Jorand Lebrun4, Herbert Y Lin5, Ravi I Thadhani6, Harsukh Parmar1 and Julie A DeMartino1, 1TIP Immunology, EMD Serono, Inc, Billerica, MA, 2EMD Serono, Inc, Billerica, MA, 3TIP Immunology, EMD Serono, Inc, Billeria, MA, 4Discovery Technology, EMD Serono, Inc, Billerica, MA, 5Division of Nephrology, Massachusetts General Hospital, Boston, MA, 6Divison of Nephrology, Massachusetts General Hospital, Boston, MA

    Background/Purpose: Interleukin-1 receptor (IL-1R)-associated kinase 4 (IRAK4) is a key component of the Myddosome complex, which is essential for signalling downstream of IL-1R and most…
  • Abstract Number: 382 • 2016 ACR/ARHP Annual Meeting

    Tumor Necrosis Factor-α -308 a/G Gene Polymorphism in Children with Juvenile Idiopathic Arthritis: Relation to Disease Activity, Damage and Disability

    Tamer Gheita1, Iman El Gazzar2, Hanan Fathy3, Abeer Nour El-Din4, Enas Abdel Rasheed5, Rasha Bassyouni6 and Sanaa Kenawy7, 1Rheumatology, Rheumatology Department, Faculty of Medicine, Cairo University, Egypt, Cairo, Egypt, 2Rheumatology, Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt, 3Rheumatology, Rheumatology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt, 4Pediatric Department, National Research Centre, Dokki, Egypt, Giza, Egypt, 5Clinical Pathology Department, National Research Centre, Dokki, Egypt, Giza, Egypt, 6Medical Microbiology and Immunology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt, 7Pharmacology, Pharmacology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of childhood and an important cause of disability. Its cause remains unknown, but…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 31
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology